• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Geron Announces
Collaboration with Janssen

Click here for important information

 

Geron News

12.16.2014

Geron Announces Early HSR Clearance for Global Strategic Collaboration with Janssen

Read More

12.5.2014

Geron to Host Analyst and Investor Meeting on December 8

Read More

12.4.2014

Geron Announces Publication of Preclinical Data on Imetelstat Activity in Acute Myelogenous Leukemia

Read More

 

Events

12.08.2014

Geron Hosts Analyst and Investor Meeting

Listen to Webcast

Download Presentation

12.03.2014

Geron Presents at the Piper Jaffray Healthcare Conference

Listen to Webcast

11.19.2014

Geron Presents at the Stifel Healthcare Conference

Listen to Webcast

Download Presentation

11.14.2014

Conference call to discuss the global stragic collaboration with Janssen

Listen to Webcast